Tim Eisen

Tim Eisen is currently the Franchise Head of GU Oncology at Roche and serves as a Professor of Medical Oncology at the University of Cambridge. Previously, they held the position of Vice President of AstraZeneca Oncology Early Clinical Development, leading a team responsible for over 160 clinical trials globally. Tim has published over 200 peer-reviewed articles, achieving significant recognition in the field, and they have been elected a Fellow of the Academy of Medical Sciences. Their major research contributions include pioneering studies on BRAF inhibitors in melanoma and the development of new treatments for renal cell carcinoma. Tim also serves as a trustee for Macmillan Cancer Support and has contributed to patient support charities, enhancing the intersection of clinical practice and community outreach.